scholarly article | Q13442814 |
P50 | author | Marie-Laure Joly-Guillou | Q3292024 |
Didier Raoult | Q915676 | ||
Pierre-Édouard Fournier | Q21337923 | ||
Philippe Colson | Q30322467 | ||
Jean-Marc Rolain | Q34572450 | ||
Laurent Papazian | Q34574633 | ||
Grégory Dubourg | Q88357378 | ||
Seydina M Diene | Q89682563 | ||
Hervé Richet | Q114421288 | ||
P2093 | author name string | Marie Kempf | |
Amandina Ribeiro | |||
Saïd Azza | |||
P2860 | cites work | Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | Q29616600 |
Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital | Q33967629 | ||
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii | Q34042171 | ||
Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium | Q34564018 | ||
Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain | Q34740954 | ||
Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France | Q35793194 | ||
Antimicrobial resistance of Acinetobacter spp. in Europe | Q35859069 | ||
Clinical impact and pathogenicity of Acinetobacter. | Q36282248 | ||
The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
Multilocus sequence typing of bacteria | Q36506797 | ||
Acinetobacter infections: a growing threat for critically ill patients | Q36950581 | ||
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization | Q37302581 | ||
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea | Q37485601 | ||
Acinetobacter: an old friend, but a new enemy | Q37584808 | ||
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options | Q37960325 | ||
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species | Q38471963 | ||
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. | Q42112359 | ||
Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals | Q42167294 | ||
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii | Q42625400 | ||
Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey | Q43050924 | ||
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting | Q43758287 | ||
Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital | Q44454731 | ||
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England | Q45121470 | ||
Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit | Q45250698 | ||
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. | Q45933628 | ||
Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution | Q46845603 | ||
A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: antimicrobial and organizational strategies | Q48276480 | ||
Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain. | Q50691534 | ||
Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. | Q54377704 | ||
Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France | Q56572609 | ||
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain | Q58387204 | ||
Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany | Q58573884 | ||
P433 | issue | 1 | |
P921 | main subject | carbapenem antibiotic | Q410897 |
Acinetobacter baumannii | Q3241189 | ||
P304 | page(s) | 64-71 | |
P577 | publication date | 2012-06-28 | |
P1433 | published in | Acta Pathologica et Microbiologica Scandinavica | Q15756643 |
P1476 | title | Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation | |
P478 | volume | 121 |
Q92436443 | Co-existence of blaOXA-23 and blaVIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital |
Q31031679 | EPIMIC: A Simple Homemade Computer Program for Real-Time EPIdemiological Surveillance and Alert Based on MICrobiological Data |
Q55429851 | Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru. |
Q35982095 | Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar |
Q41918992 | Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain |
Q42930254 | Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia |
Q61801155 | Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon |
Q35534215 | Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods |
Q34724617 | Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France |
Q34058579 | New PCR-based open reading frame typing method for easy, rapid, and reliable identification of Acinetobacter baumannii international epidemic clones without performing multilocus sequence typing |
Q35897061 | Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France |
Q36505442 | Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France |
Q37625333 | Spread of the blaOXA-23-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China |
Q40965515 | Task force on management and prevention of Acinetobacter baumannii infections in the ICU. |
Q50880929 | The long-term survival of Acinetobacter baumannii ATCC 19606(T) under nutrient-deprived conditions does not require the entry into the viable but non-culturable state. |
Search more.